{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:07:19Z","timestamp":1791324439395,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.mrgentox.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T02:55:36Z","timestamp":1316228136000},"page":"181-187","source":"Crossref","is-referenced-by-count":6,"title":["Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro"],"prefix":"10.1016","volume":"726","author":[{"given":"Shambhu K.","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Eastmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2011.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jnci\/85.14.1102","article-title":"Survivors of childhood cancer and risk of a second tumor","volume":"85","author":"Robison","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.2007.06613.x","article-title":"Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia","volume":"137","author":"Seedhouse","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00001813-199112000-00003","article-title":"Generation of DNA damage by anti-neoplastic agents","volume":"2","author":"Kubota","year":"1991","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.leu.2405078","article-title":"Genetics of therapy-related myelodysplasia and acute myeloid leukemia","volume":"22","author":"Pedersen-Bjergaard","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0025","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood.V86.9.3542.bloodjournal8693542","article-title":"Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia","volume":"86","author":"Pedersen-Bjergaard","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<337::AID-GCC9>3.0.CO;2-L","article-title":"Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases","volume":"23","author":"Pedersen-Bjergaard","year":"1998","journal-title":"Gene. Chromosome. Canc."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2141.2001.03000.x","article-title":"Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992","volume":"114","author":"Andersen","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0040","first-page":"577","article-title":"Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)","volume":"15","author":"Zhang","year":"1980","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1346-8138.1991.tb03161.x","article-title":"Efficacy of bimolane in the Malassezia ovalis model of psoriasis","volume":"18","author":"Xu","year":"1991","journal-title":"J. Dermatol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0167-4781(98)00133-X","article-title":"Catalytic inhibitors of DNA topoisomerase II","volume":"1400","author":"Andoh","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0055","first-page":"4903","article-title":"Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives","volume":"51","author":"Tanabe","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00303-0","article-title":"Bimolane: in vitro inhibitor of human topoisomerase II","volume":"120","author":"Frantz","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0065","first-page":"669","article-title":"Leukemia associated with bimkolane","volume":"33","author":"Ye","year":"1994","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0145-2126(92)90050-H","article-title":"Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis","volume":"16","author":"Xue","year":"1992","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0075","first-page":"668","article-title":"140 cases of acute leukemia caused by bimolane","volume":"32","author":"Zhang","year":"1993","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0080","first-page":"17","article-title":"Preliminary studies of the relationship between micronucleus formation and cell cycle. IV. Micronucleus formation induced by chemical mutagens at G0, G1, S and G2 phases of human lymphocytes","volume":"19","author":"Xue","year":"1992","journal-title":"Yi Chuan Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0085","first-page":"464","article-title":"Nuclear anomaly test in human lymphocytes in vitro","volume":"13","author":"Xue","year":"1992","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0090","first-page":"87","article-title":"Effects of bimolane on cell cycle cytokinesis in human lymphocytes in vitro","volume":"15","author":"Xue","year":"1994","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0095","first-page":"531","article-title":"Mutagenic effects of bimolane","volume":"16","author":"Chen","year":"1995","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0165-1218(89)90079-7","article-title":"Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents","volume":"224","author":"Eastmond","year":"1989","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/em.2850130104","article-title":"Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody","volume":"13","author":"Eastmond","year":"1989","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/mutage\/18.3.235","article-title":"Noscapine hydrochloride-induced numerical aberrations in cultured human lymphocytes: a comparison of FISH detection methods and multiple end-points","volume":"18","author":"Schuler","year":"2003","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mrgentox.2004.07.002","article-title":"Corrigendum to \u201cReport from the in vitro micronucleus assay working group\u201d","volume":"564","author":"Kirsch-Volders","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-1161(85)90015-9","article-title":"Measurement of micronuclei in lymphocytes","volume":"147","author":"Fenech","year":"1985","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0091-679X(08)60542-7","article-title":"Fluorescence in situ hybridization with DNA probes","volume":"33","author":"Trask","year":"1990","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/mutage\/10.6.471","article-title":"A method for the rapid generation of alpha- and classical satellite probes for human chromosome 9 by polymerase chain reaction using genomic DNA and their application to detect chromosomal alterations in interphase cells","volume":"10","author":"Hasegawa","year":"1995","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/em.2860080203","article-title":"Statistical analyses for in vitro cytogenetic assays using Chinese hamster ovary cells","volume":"8","author":"Margolin","year":"1986","journal-title":"Environ. Mutagen"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0140","first-page":"185","article-title":"Risk factors analysis of leukemia and aplastic anemia in China","volume":"14","author":"Chinese Epidemiologic Study Group of Leukemia and Aplastic Anemia","year":"1992","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-4274(98)00353-1","article-title":"Are topoisomerase II inhibitor-induced micronuclei in vitro a predictive marker for the compounds\u2019 ability to cause secondary leukemias after treatment?","volume":"104","author":"Stopper","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/em.10072","article-title":"Catalytic inhibitors of topoisomerase II are DNA-damaging agents: induction of chromosomal damage by merbarone and ICRF-187","volume":"39","author":"Wang","year":"2002","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0155","first-page":"4909","article-title":"Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors","volume":"51","author":"Ishida","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0160","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-2952(95)00218-O","article-title":"A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)","volume":"50","author":"Hasinoff","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0165","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1073\/pnas.91.5.1781","article-title":"Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp","volume":"91","author":"Roca","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mrfmmm.2006.11.023","article-title":"Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells","volume":"616","author":"Wang","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1083\/jcb.126.6.1341","article-title":"Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events","volume":"126","author":"Ishida","year":"1994","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)38928-1","article-title":"The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells","volume":"295","author":"Hasinoff","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/187152010793498654","article-title":"Antimetastatic activities and mechanisms of bisdioxopiperazine compounds","volume":"10","author":"Lu","year":"2010","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tcb.2009.01.006","article-title":"The actin cytoskeleton in spindle assembly and positioning","volume":"19","author":"Kunda","year":"2009","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceb.2006.02.002","article-title":"Rho GTPases in animal cell mitosis","volume":"18","author":"Narumiya","year":"2006","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.6474171","article-title":"Bimolane: structure determination indicates anticancer activity is attributable to ICRF-154","volume":"225","author":"Camerman","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cbi.2009.12.023","article-title":"Topoisomerase II inhibition by the bioactivated benzene metabolite hydroquinone involves multiple mechanisms","volume":"184","author":"Mondrala","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0210","first-page":"1","article-title":"Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans","author":"Eastmond","year":"2001","journal-title":"Res. Rep. Health Eff. Inst."},{"key":"10.1016\/j.mrgentox.2011.09.006_bib0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbi.2009.10.017","article-title":"A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification","volume":"184","author":"Wong","year":"2010","journal-title":"Chem. Biol. Interact."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571811002713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571811002713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T14:38:33Z","timestamp":1741703913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571811002713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1383571811002713"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2011.09.006","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}